Skip to main content
. 2017 Nov 28;117(6):1072–1082. doi: 10.1160/TH17-01-0068

Figure 4: Hazard ratio of stroke/SE (A) and major bleeding (B) according to subgroups in propensity score matched apixaban and warfarin patients.

Figure 4: Hazard ratio of stroke/SE (A) and major bleeding (B) according to subgroups in propensity score matched apixaban and warfarin patients

. CI: confidence interval. a p-value in the figure is for interaction. b age, gender, geographical region, CCI, CHA 2 DS 2 -VASc, HAS-BLED, congestive heart failure, hypertension, renal disease, baseline proton pump inhibitor use, and baseline antiplatelets use were included in the model. c CCI was included in the model.